Identification of Polymorphic Form
XRPD confirmation of API identity and polymorphic form vs. reference standards
Overview
To confirm the identity of a pharmaceutical in comparison to a reference, in most cases it is sufficient to prove that there is a match between the measured XRPD peak positions and the reference peak positions. We offer a detection bandwidth between the reference and the measured peak positions one order of magnitude better than what is required by the European Pharmacopoeia <2.9.33>.
Technology: Peak position accuracy is improved thanks to new aberration correction techniques based on V.A. Kogan patent US20060206278A1 (new patent filed in 2025, pending).